These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 32698806)

  • 21. Strategies for Targeted Delivery of Exosomes to the Brain: Advantages and Challenges.
    Choi H; Choi K; Kim DH; Oh BK; Yim H; Jo S; Choi C
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody screening using a human iPSC-based blood-brain barrier model identifies antibodies that accumulate in the CNS.
    Georgieva JV; Goulatis LI; Stutz CC; Canfield SG; Song HW; Gastfriend BD; Shusta EV
    FASEB J; 2020 Sep; 34(9):12549-12564. PubMed ID: 32960493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of basigin monoclonal antibodies for receptor-mediated drug delivery to the brain.
    Christensen SC; Krogh BO; Jensen A; Andersen CBF; Christensen S; Nielsen MS
    Sci Rep; 2020 Sep; 10(1):14582. PubMed ID: 32884039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of the transcytosis of an anti-transferrin receptor antibody with a Fab' cargo across the blood-brain barrier in mice.
    Manich G; Cabezón I; del Valle J; Duran-Vilaregut J; Camins A; Pallàs M; Pelegrí C; Vilaplana J
    Eur J Pharm Sci; 2013 Jul; 49(4):556-64. PubMed ID: 23748097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional validation of the simplified in vitro 3D Co-culture based BBB model.
    Kim W; Kim J; Lee SY; Kim HM; Jung H; Joo KM; Nam DH
    Biochem Biophys Res Commun; 2022 Oct; 625():128-133. PubMed ID: 35961136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies to identify, engineer, and validate antibodies targeting blood-brain barrier receptor-mediated transcytosis systems for CNS drug delivery.
    Choi ES; Shusta EV
    Expert Opin Drug Deliv; 2023; 20(12):1789-1800. PubMed ID: 38007619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood-brain barrier transport of therapeutics via receptor-mediation.
    Jones AR; Shusta EV
    Pharm Res; 2007 Sep; 24(9):1759-71. PubMed ID: 17619996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sorting Tubules Regulate Blood-Brain Barrier Transcytosis.
    Villaseñor R; Schilling M; Sundaresan J; Lutz Y; Collin L
    Cell Rep; 2017 Dec; 21(11):3256-3270. PubMed ID: 29241551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain delivery of biologics using a cross-species reactive transferrin receptor 1 VNAR shuttle.
    Sehlin D; Stocki P; Gustavsson T; Hultqvist G; Walsh FS; Rutkowski JL; Syvänen S
    FASEB J; 2020 Oct; 34(10):13272-13283. PubMed ID: 32779267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transferrin receptor expression and role in transendothelial transport of transferrin in cultured brain endothelial monolayers.
    Hersom M; Helms HC; Pretzer N; Goldeman C; Jensen AI; Severin G; Nielsen MS; Holm R; Brodin B
    Mol Cell Neurosci; 2016 Oct; 76():59-67. PubMed ID: 27567687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiological blood-brain transport is impaired with age by a shift in transcytosis.
    Yang AC; Stevens MY; Chen MB; Lee DP; Stähli D; Gate D; Contrepois K; Chen W; Iram T; Zhang L; Vest RT; Chaney A; Lehallier B; Olsson N; du Bois H; Hsieh R; Cropper HC; Berdnik D; Li L; Wang EY; Traber GM; Bertozzi CR; Luo J; Snyder MP; Elias JE; Quake SR; James ML; Wyss-Coray T
    Nature; 2020 Jul; 583(7816):425-430. PubMed ID: 32612231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor-mediated transcytosis of macromolecules across the blood-brain barrier.
    Baghirov H
    Expert Opin Drug Deliv; 2023; 20(12):1699-1711. PubMed ID: 37658673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain microvascular endothelial cells derived from human induced pluripotent stem cells as
    Piantino M; Louis F; Shigemoto-Mogami Y; Kitamura K; Sato K; Yamaguchi T; Kawabata K; Yamamoto S; Iwasaki S; Hirabayashi H; Matsusaki M
    Mater Today Bio; 2022 Mar; 14():100232. PubMed ID: 35308041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier.
    Pflanzner T; Janko MC; André-Dohmen B; Reuss S; Weggen S; Roebroek AJ; Kuhlmann CR; Pietrzik CU
    Neurobiol Aging; 2011 Dec; 32(12):2323.e1-11. PubMed ID: 20630619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A filter-free blood-brain barrier model to quantitatively study transendothelial delivery of nanoparticles by fluorescence spectroscopy.
    De Jong E; Williams DS; Abdelmohsen LKEA; Van Hest JCM; Zuhorn IS
    J Control Release; 2018 Nov; 289():14-22. PubMed ID: 30243824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcellular trafficking and transcytosis efficacy of different receptor types for therapeutic antibody delivery at the blood‒brain barrier.
    Holst MR; de Wit NM; Ozgür B; Brachner A; Hyldig K; Appelt-Menzel A; Sleven H; Cader Z; de Vries HE; Neuhaus W; Jensen A; Brodin B; Nielsen MS
    Fluids Barriers CNS; 2023 Nov; 20(1):82. PubMed ID: 37932749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcytosis of macromolecules at the blood-brain barrier.
    Preston JE; Joan Abbott N; Begley DJ
    Adv Pharmacol; 2014; 71():147-63. PubMed ID: 25307216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization, receptor mapping and blood-brain barrier transcytosis of antibodies to the human transferrin receptor.
    Friden PM; Olson TS; Obar R; Walus LR; Putney SD
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1491-8. PubMed ID: 8819537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered blood-brain barrier transport of nanotherapeutics in lysosomal storage diseases.
    Solomon M; Loeck M; Silva-Abreu M; Moscoso R; Bautista R; Vigo M; Muro S
    J Control Release; 2022 Sep; 349():1031-1044. PubMed ID: 35901858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced Delivery of Galanin Conjugates to the Brain through Bioengineering of the Anti-Transferrin Receptor Antibody OX26.
    Thom G; Burrell M; Haqqani AS; Yogi A; Lessard E; Brunette E; Delaney C; Baumann E; Callaghan D; Rodrigo N; Webster CI; Stanimirovic DB
    Mol Pharm; 2018 Apr; 15(4):1420-1431. PubMed ID: 29485883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.